CD68 and metabolic dysfunction-associated steatohepatitis: Clinical evidence indicates that NASH patients with NAS scores > 4 display both increased intrahepatic Foxp3+ Tregs populations correlating with inflammatory severity and expanded CD68+ Macrophages regions (95).